Loading...

Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation.

The release of aspirin from a 75 mg controlled-release formulation, designed to inhibit maximally thromboxane A2 production while sparing stimulated prostacyclin biosynthesis, was characterised in healthy subjects. The calculated in vivo release rate of aspirin matched the design goal of approximate...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Charman, W N, Charman, S A, Monkhouse, D C, Frisbee, S E, Lockhart, E A, Weisman, S, Fitzgerald, G A
Format: Artigo
Sprog:Inglês
Udgivet: 1993
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1364623/
https://ncbi.nlm.nih.gov/pubmed/12959298
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!